The role of mitogen-activated protein kinases and the participation of intestinal congestion in total hepatic ischemia-reperfusion injury

Hepato-Gastroenterology

Volumn 53, Issue 68, 2006, Pages 243-248

  Kobayashi, Mitsunobu ^a   Takeyoshi, Izumi ^a   Yoshinari, Daisuke ^a   Matsumoto, Koshi ^b   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

Author keywords

Hepatic ischemia reperfusion injury; Interteukin 1 ; Intestinal congestion; Intracellular signal transaction; Mitogen activated protein kinase; Tumor necrosis factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HISTOPATHOLOGY; LIVER ISCHEMIA; MALE; NONHUMAN; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; TISSUE BLOOD FLOW;

ANIMALS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; INTESTINES; LIVER DISEASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; PORTASYSTEMIC SHUNT, SURGICAL; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 33645558737     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Atalla SL, Toledo-Peretra LH, Mackenzie GH, Cederna, JP: Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation 1985; 40:584-590.
2. Young CS, Palma JM, Mosher BD, Harkema J, Naylor DF, Dean RE, Crockett E: Hepatic ischemia/reperfusion injury in P-selectin and intercellular adhesion molecule-1 double-mutant mice. Am Surg 2001; 67:737-744.
3. Uchida M, Takemoto Y, Nagasue N, Dhar DK, Kohno H, Nakamura T: Effect of verapamil on hepatic reperfusion injury after prolonged ischemia in pigs. J Hepatol 1994; 21:217-223.
4. Chen HM, Chen JC, Shyr MH, Chen MF, Hwang TL, Fan LL, Chi TY, Chi CP: Neutrophil elastase inhibitor (ONO-5046) attenuates reperfusion-induced hepatic microcirculatory derangement, energy depletion and lipid peroxidation in rats. Shock 1999; 12:462-467.
5. Quiroga J, Prieto J: Liver cytoprotection by prostaglandins. Pharmacol Ther 1993; 58:67-91.
6. Travis DL, Fabia R, Netto GG, Husberg BS, Goldstein RM, Klintnialm GB, Levy MF: Protection by cyclosporine A against normothermic liver ischemia-reperfusion in pigs. J Surg Res 1998; 75:116-126.
7. Aiba M, Takeyoshi I, Ohwada S, Kawashinia Y, Iwanami K, Sunose Y, Yamada T, Tsutsumi H, Matsumoto K, Morishita Y: Novel nitric oxide donor (FK409) ameliorates liver damage during extended liver resection with warm ischemia in dogs. J Am Coll Surg 2001; 193:264-271.
8. Andus T, Bauer J, Gerok W: Effects of cytokines on the liver. Hepatology 1991; 13:364-375.
9. Raffucci FL, Wangensteen OH: Tolerance of dogs to occlusion of entire afferent vascular inflow to the liver. Surg Forum 1950; 1:191-195.
10. Davis RJ: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993; 268:14553-14556.
11. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270:1326-1331.
12. Koibuchi Y, Iino Y, Uchida T, Nagasawa M, Morishita Y: Effects of estrogen and tamoxifen on the MAP kinases cascade in experimental rat breast cancer. Int J Oncol 1997; 11:583-589.
13. Bogoyevitch MA, Ketterman AJ, Sugden PH: Cellular stresses differentially activate c-Jun N-terminal protein kinase and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem 1995; 270:29710-29717.
14. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodget JR: The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994; 369:156-160.
15. Wang X, Martindale JL, Liu Y, Holbrook NJ: The cellular response to oxidative stress: influence of mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270:7420-7426.
16. Seth A, Gonzalez FA, Gupta S, Raden DL, Davis RJ: Signal transduction within the nucleus by mitogen-activated protein kinase. J Biol Chem 1992; 267:24796-24804.
17. Han J, Lee JD, Bibbs L, Ulevitch RJ: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994; 265:808-811.
18. Kobayashi M, Takeyoshi I, Yoshinari D, Matsumoto K, Morishita Y: p38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver. Surgery 2002; 131:344-349.
19. Yue TL, Wang C, Gu JL, Ma XL, Kumar S, Lee JC, Fuerstein GZ, Thomas H, Maleeff B, Ohlstein EH: Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 2000; 86:692-699.
20. Suzuki S, Nakamura S, Sakaguchi T, Mitsuoka H, Tsuchiya Y, Kojima Y, Konno H, Baba S: Pathophysiological appraisal of a rat model of total hepatic ischemia with an extracorporeal portosystemic shunt. J Surg Res 1998; 80:22-27.
21. Sankary HN, Foster P, Brown E, Williams J: Do splanchnic viscera contribute to liver preservation reperfusion injury? Transplantation 1996; 61:1142-1147.
22. Clerk A, Fuller SJ, Micheal A, Sudgen PH: Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinase/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stress. J Biol Chem 1998; 273:7228-7234.
23. De Silva H, Cioff C, Yin T, Sandhu G, Webb RL, Whelan J: Identification of a novel stress-activated kinase in kidney and heart. Biochem Biophys Res Commun 1998; 250:647-652.
24. Yin T, Sandhu G, Wolfgang CD, Burrier A, Webb RL, Rigel DF, Hai T, Whelan J: Tissue specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem 1997; 272:19943-19950.
25. Gupta S, Campbell D, Derijard B, Davis RJ: Transcription factor ATF-2 regulation by the JNK signal transduction pathway. Science 1995; 267:389-393.
26. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ: Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270:7420-7426.
27. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD: ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 1991; 65:663-675.
28. Donnahoo KK, Shames BD, Harken AH, Meldrum DR: Review article: The role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 1999; 162:196-203.
29. Cain BS, Meldrum DR, Meng X, Dinarello CA, Shames BD, Banerjee A, Harken AH: p38 MAPK inhibition decreases TNF-alpha production and enhances postischemic human myocardial function. J Surg Res 1999; 83:7-12.
30. Yoshinari D, Takeyoshi I, Koibuchi Y, Matsumoto K, Kawashima Y, Koyama T, Ohwada S, Morishita Y: Effects of a dual inhibitor of tumor necrosis factor-α and interleukin-1 on lipopolysaccharide-induced lung injury in rats: Involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med 2001; 29:628-634.
31. Bendinelli P, Piccoletti R, Maroni P, Bernelli-Zazzera A: The MAP kinase cascades are activated during post-ischemic liver reperfusion. FEBS Lett 1996; 398:193-197.